Follow

Dignitana publishes January newsletter

14 January 2021 - 08:32

Dignitana AB today publishes the January newsletter featuring strong opportunities for the company with Mammazentrum Hamburg and GenesisCare in Australia as well as details from the recent Directed Share IssueTo read the newsletter click here or visit Dignitana.com.

The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.se as part of Dignitana's commitment to provide ongoing communication to the market. To receive future Dignitana news directly to your email, subscribe here.

 

Dignitana announces that as of 15 April 2021 the company will only provide press releases and interim reports in English. The company's annual reports will continue to be published in both Swedish and English.

Dignitana meddelar att bolaget från och med 15 april 2021 endast kommer att tillhandahålla pressmeddelanden och delårsrapporter på engelska. Bolagets årsredovisningar kommer även  fortsättningsvis att publiceras på både svenska och engelska.

 

 

For More Information Contact 

Melissa Bourestom, VP Corporate Communications melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, certifiedadviser@redeye.se. Learn more at www.dignitana.se or www.dignicap.com

Provided by: Cision
Nasdaq First North GM (Sweden)
Dignitana AB
Dignitana AB is a medical technology company, that develops, produces and markets The DigniCap Scalp Cooling System. It is a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy to improve well-being and quality of life. Its operations are based in Dallas, Texas in the United States....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date